Cite
HARVARD Citation
Chalasani, P. et al. (2014). A Pilot Study of Estradiol Followed by Exemestane for Reversing Endocrine Resistance in Postmenopausal Women With Hormone Receptor-Positive Metastatic Breast Cancer. Oncologist. pp. 1127-1128. [Online].